Clinical Trial Update: A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population [Phase 4]

View source ↗

Summary

A Phase IIIB/IV trial comparing vancomycin to extended-duration fidaxomicin for clinical cure of Clostridioides difficile infection in older adults has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fidaxomicin (fidaxomicin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Clostridium Difficile | Phase 4 | Status: COMPLETED